AnaptysBio Inc (NASDAQ: ANAB) on Friday, soared 12.11% from the previous trading day, before settling in for the closing price of $21.14. Within the past 52 weeks, ANAB’s price has moved between $12.21 and $41.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 62.73% over the past five years. The company achieved an average annual earnings per share of -2.88%. With a float of $26.48 million, this company’s outstanding shares have now reached $30.39 million.
Let’s look at the performance matrix of the company that is accounted for 136 employees. In terms of profitability, gross margin is 98.94%, operating margin of -89.64%, and the pretax margin is -125.66%.
AnaptysBio Inc (ANAB) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of AnaptysBio Inc is 9.88%, while institutional ownership is 128.18%. The most recent insider transaction that took place on Dec 30 ’24, was worth 842,060. In this transaction Director of this company bought 65,184 shares at a rate of $12.92, taking the stock ownership to the 7,860,180 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director bought 13,268 for $12.93, making the entire transaction worth $171,513. This insider now owns 7,873,448 shares in total.
AnaptysBio Inc (ANAB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -2.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.22% during the next five years compared to -7.30% drop over the previous five years of trading.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
AnaptysBio Inc (ANAB) is currently performing well based on its current performance indicators. A quick ratio of 8.25 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.84, a number that is poised to hit -1.53 in the next quarter and is forecasted to reach -4.96 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
AnaptysBio Inc (NASDAQ: ANAB) saw its 5-day average volume 1.13 million, a positive change from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 49.38%. Additionally, its Average True Range was 1.76.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 92.14%, which indicates a significant increase from 82.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.45% in the past 14 days, which was lower than the 87.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.09, while its 200-day Moving Average is $22.77. Nevertheless, the first resistance level for the watch stands at $24.83 in the near term. At $25.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $27.91. If the price goes on to break the first support level at $21.75, it is likely to go to the next support level at $19.80. Assuming the price breaks the second support level, the third support level stands at $18.67.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
Market capitalization of the company is 696.32 million based on 29,380K outstanding shares. Right now, sales total 91,280 K and income totals -145,230 K. The company made 27,770 K in profit during its latest quarter, and -39,330 K in sales during its previous quarter.
